跳到正文
原文
Servier· @Servier · X·· 2 小时前AI 评分8
AI 导读

施维雅在贝克尔肌营养不良症宣传周重申对罕见神经肌肉疾病患者的承诺,指出该领域仍存在显著未满足医疗需求。公司表示正推进罕见神经疾病研究,目标是到2030年成为全球罕见神经疾病领域领导者。

正文

🧬 During #BeckerMuscularDystrophy Awareness Week, we reaffirm our commitment to people living with rare neuromuscular diseases.
Becker muscular dystrophy is one of the areas where significant unmet medical needs remain. we are committed to advancing research in rare neurological disorders and addressing unmet patient needs. At Servier, our ambition is to become a global leader in rare neurological diseases by 2030. 
Learn more about Becker muscular dystrophy 🔗 https://f.mtr.cool/i6vt63lbyc
#WeAreServier #MovedByYou #RareDisease #Neurology

来源:Servier · x.com